Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and ShadowsMaria Chianese, Barbara Ruaro, Gianluca Screm et al.|Pharmaceuticals|2024Cited by 86
miR-200 family members reduce senescence and restore idiopathic pulmonary fibrosis type II alveolar epithelial cell transdifferentiationSilvia Moimas, Marco Confalonieri|ERJ Open Research|2019Cited by 59
The time to offer treatments for COVID-19Binh Ngo, Ivan Fan‐Ngai Hung, Paul E. Marik et al.|Expert Opinion on Investigational Drugs|2021Cited by 32
Nailfold Video-Capillaroscopy in Sarcoidosis: New Perspectives and ChallengesMaria Chianese, Barbara Ruaro, Gianluca Screm et al.|Tomography|2024Cited by 7
The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary FibrosisStefano Kette, Barbara Ruaro, Nicolò Reccardini et al.|Pharmaceuticals|2025Cited by 6